First-Line Biologics for Moderate-to-Severe Psoriasis

Multiple therapeutic options exist for moderate-to-severe psoriasis, each with unique benefits and limitations. This review offers guidance on choosing the optimal therapy for your patients.
American Journal of Clinical Dermatology

http://ift.tt/2EQreqc